Mergers and acquisitions
The AI brokerage company, which launched in January with $60 million in funding, announced its acquisition of Medicare brokerage agency Avid Health earlier this month.
The acquisition will enable Stryker to expand its portfolio with intravascular lithotripsy technology from Amplitude Vascular Systems for treating severely calcified arteries.
The acquisition will allow Noom to expand beyond weight loss into prescription-grade wellness, including peptide therapies and healthy aging services.
The deal will combine digital engagement tools and on-site clinical services to help employers and health plans better manage risk and support employee health.
The acquisition allows Cerebral to offer ADHD patients ongoing support through therapy, skill-building modules, medication management and community engagement.
The company acquired Intelerad for $2.3 billion in cash and debt financing and expects around $270 million in recurring annual revenue and a high-single-digit return on investment within five years.
The Helsinki‑based company offers AI-enabled biometric and gesture recognition technology that allows for device control with natural movements.
Rivalling OpenEvidence and DoxGPT, Heidi’s latest offering, Heidi Evidence, sets itself apart by allowing clinicians to upload their own sources and documents.
The acquisition of the international telehealth company will allow Hims & Hers to expand its presence in Australia, Japan, Germany, Canada and the UK.
Following the acquisition, April Koh will continue as CEO to lead Spring Health and Harry Ritter will remain CEO of Alma as the brands operate separately.